CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer. (Q37358248)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Gianmaria Pennelli

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Marco Volante

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Filomena Cetani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Chiara Banti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Elena Pardi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Simona Borsari

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Paolo Viacava

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Paolo Miccoli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Liborio Torregrossa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Maria Rosa Pelizzo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Massimo Rugge

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Guido Gasparri

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Mauro Papotti

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Edda Vignali

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Federica Saponaro

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Claudio Marcocci

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

28 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

published in

Endocrine Connections

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

186-195

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

Oncogenic microRNA-155 down-regulates tumor suppressor CDC73 and promotes oral squamous cell carcinoma cell proliferation: implications for cancer therapeutics

28 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3847926

Novel HRPT2/CDC73 gene mutations and loss of expression of parafibromin in Chinese patients with clinically sporadic parathyroid carcinomas

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3847926

Clinical practice. Primary hyperparathyroidism

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3847926

Parathyroid carcinoma: a 43-year outcome and survival analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3847926

The DNA methylome of benign and malignant parathyroid tumors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3847926

Somatic and Germ-Line Mutations of theHRPT2Gene in Sporadic Parathyroid Carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3847926

HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3847926

HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3847926

Hyperparathyroid and hypoparathyroid disorders

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3847926

Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3847926

Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3847926

Parathyroid carcinoma.A study of 70 cases

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3847926

Natural history of parathyroid carcinoma. Diagnosis, treatment, and results

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3847926

Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3847926

Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3847926

Defining a molecular phenotype for benign and malignant parathyroid tumors

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3847926

CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3847926

Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma

3 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3847926

3 December 2018

1 reference

12 December 2020

Frequent Large GermlineHRPT2Deletions in a French National Cohort of Patients With Primary Hyperparathyroidism

1 reference

12 December 2020

Aberrant methylation of the HRPT2 gene in parathyroid carcinoma

1 reference

12 December 2020

Loss of parafibromin expression in a subset of parathyroid adenomas

1 reference

12 December 2020

Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias

1 reference

12 December 2020

Parathyroid carcinoma

1 reference

12 December 2020

Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma

1 reference

12 December 2020

HRPT2 mutational analysis of typical sporadic parathyroid adenomas

1 reference

12 December 2020

Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification

1 reference

12 December 2020

Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors

1 reference

12 December 2020

Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?

1 reference

12 December 2020

Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma

1 reference

12 December 2020

Parathyroid carcinoma: a 22-year experience

1 reference

12 December 2020

Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas

1 reference

12 December 2020

Identifiers

DOI

10.1530/EC-13-0046

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24145611%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference